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Background: There is compelling evidence that infections with non-typeable Haemophilus in-
fluenzae (NTHi) are associated with exacerbations in COPD patients. However, NTHi has also
been isolated frequently during clinically stable disease. In this study we tested the hypoth-
esis that genetically distinct NTHi isolates obtained from COPD patients differ in virulence
which could account for dissimilarities in the final outcome of an infection (stable vs. exac-
erbation).
Results: NTHi isolates (n Z 32) were obtained from stable COPD patients, or during exacer-
bations. Genetically divergent NTHi isolates were selected and induction of inflammation
was assessed as an indicator of virulence using different in vitro models. Despite marked
genomic differences among NTHi isolates, in vitro studies could not distinguish between
NTHi isolates based on their inflammatory capacities. Alternatively, when using a whole
blood assay results demonstrated marked inter-, but not intra-individual differences ins performed within the framework of Dutch Top Institute Pharma; project “Exploitation of Toll-like
r. D1-101)”.
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Bacterial infections in COPD exacerbations 145cytokine release between healthy volunteers irrespective of the origin of the NTHi isolate
used.
Conclusion: Results suggest that the individual immune reactivity might be an important
predictor for the clinical outcome (exacerbation vs. no exacerbation) following NTHi
infection.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Acute exacerbations (AE) are responsible for an enormous
burden in the clinical course of chronic obstructive pulmo-
nary disease (COPD) [1,2]. Regarding the cause of these AEs,
a strong link between AEs and bacterial as well as viral in-
fections has been shown [2e5]. In particular the non-
typeable Haemophilus influenzae (NTHi) Gram-negative
bacterium has been associated frequently with acute exac-
erbations [2,6,7]. However, a direct cause-effect relation-
ship is lacking since NTHi has been isolated from COPD
patients not only during AEs but also in clinically stable pe-
riods [8]. This raises the important question why some pa-
tients develop an exacerbation following a respiratory tract
infection while others remain stable. To answer this, previ-
ous research has primarily focused on differences in bacte-
rial load, the location of the infection or the acquisition of a
new bacterial strain [9e11]. Moreover, it has been specu-
lated that differences in virulence account for dissimilarities
in disease pathogenesis [12]. Genomic analysis of NTHi
identified candidate genes possible important for bacterial
pathogenesis. For example, genetic islands were more
prevalent in pathogenic compared to non-pathogenic NTHi
strains [13,14]. We hypothesize that among genetic distinct
NTHi strains, some strains possess characteristics thatmakes
them more pro-inflammatory than others. As NTHi does not
produce specific toxins [15], virulence of a strain can be
defined as the intensity of the inflammatory reaction
following infection using different in vitro models. In the
present study we examined whether there are significant
differences in virulence between clinical derived, geneti-
cally distinct NTHi isolates. The virulence of genetically
unrelated isolates was compared in an in vitro setting by
assessing the inflammatory response by a macrophage-like
cell line and airway epithelial cells following exposure to
the different isolates. Additionally, a clinically more rele-
vant approach was used to assess the ability of these isolates
to induce an immune response in human immune cells. We
examined the potency of the isolates to induce the release of
various pro-inflammatory cytokines in a whole blood assay
using blood of healthy young volunteers.Materials and methods
Bacterial isolates and growth conditions
Non-typeable Haemophilus influenza isolates (nZ 32) were
obtained from sputum collected from COPD patients
referred for integrated assessment and pulmonary rehabili-
tation at CIROþ, a centre of expertise for chronic organfailure in Horn, the Netherlands. The recruitment criteria for
study participation included a clinical diagnosis of COPD, a
minimal age of 40 years and a clinically stable state of dis-
ease during 4 weeks. Exclusion criteria involved the di-
agnoses of asthma or other respiratory diseases, instable
heart and/or other chronic organ failure, malignancy or use
of oral glucocorticosteroids or other immune-suppressive
medication. Sputum samples were obtained at inclusion
into the study and during periods of AE’s. An AE was diag-
nosed in case of increased dyspnea and changes in sputum
volume or purulence. Sputum was used for routine bacterial
culture. NTHi isolates were identified with standard labora-
tory procedures and stored in80 C. The ATCC 49247 strain
was included in the study as laboratory reference NTHi
strain. Bacterial isolates of NTHi were grown on chocolate
blood agar plates supplemented with vitalex (Oxoid, Wesel,
Germany) to obtain a starting inoculum of 0.5 McFarland
(1.5 108 cfu/mL) in cell culturemediumwithout FCS for the
in vitro assays. For some assays, 0.5 McFarland suspensions
were heat inactivated (HI) at 65 C for 30 min.
Pulsed-field gel electrophoresis (PFGE)
Selected isolates were subjected to PFGE essentially as
described previously [16]. Restriction digestion was per-
formed with SmaI (Invitrogen), and the reference strain
Staphylococcus aureus PS 47 used as molecular weight
marker. Patterns were analyzed with Dice comparison and
unweighted pair-group matching analysis with Gel Compare
II 3.5 (Applied Maths, Sint-Martens-Latem, Belgium). The
position tolerance was set on 2.0 and 87.0% similarity was
used as breakpoint to cluster the bands [17]. Each cluster of
related strains was defined numerically in separated groups.
Determination of NTHi virulence
Adhesion in an airway epithelial cell infection model
Type II alveolar epithelial cells (A549 cell line, ATCC CCl-
185) were cultured according to the supplier’s recommen-
dations, seeded at a density of 105 cells/mL and grown till
confluence in 24-well plates (Becton Dickinson, NJ, USA).
After 48 h, bacterial adherence to A549 cells was assessed
essentially as previously described [18]. In short, cells were
incubated for 4 h with a selection of NTHi isolates (nZ 10)
derived from COPD patients, using starting inocula of 0.5
McFarland in RPMI (Gibco, Invitrogen, Grand Island, NY,
USA) without FCS (Lonza, Verviers, Belgium). Next, non-
adherent bacteria were removed by washing with PBS,
and the cellular content was harvested with 1% saponin in
PBS (1 mL). Bacterial numbers in both the starting inoculum
as well as saponin/PBS solution were quantified by spiral
146 T.H. Geelen et al.plating and the amount of adherent bacteria was expressed
as percentage of the starting inoculum.
Cytokine production and CXCL-8 and ICAM-1 mRNA
expression
Measurements of either cytokine production or CXCL-8/
ICAM-1 mRNA expression were preformed essentially as
described before [19]. A549 cells and 0.5 McFarland sus-
pensions of different NTHi isolates (nZ 10) were prepared
as described above and co-cultured for 6 h. Supernatant
was collected for analysis of CXCL-8 production by ELISA
(R&D Systems, Minneapolis, USA) according to the manu-
facturer’s instructions. A549 cells were collected and CXCL-
8 and ICAM-1 mRNA expression was determined by RT-qPCR
as described before [20]. Relative gene expressions were
normalized to the expression of b-actin according to the
2DCt method [21].
NTHi-induced release of inflammatory cytokines by
macrophages
THP-1 cells (ATCC-TIB202 a monocytic leukemic cell line),
were maintained according to the supplier’s recommenda-
tions. Differentiation into a macrophage phenotype was
achieved by an extended protocol which drives cells to-
wards a more differentiated macrophage phenotype that
closely resemble monocyte-derived macrophages (MDM)
[22]. Following this phorbol 12-myristate 13-acetate (PMA)
differentiation period, cells were seeded in a 24-well plate
at a density of 5  104 cells/well in 900 mL in Dulbecco’s
Modified Eagle Medium-F12 (Ham) (DMEM, Gibco Invitrogen,
Grand Island, NY, USA) with 0.1% FCS. Five hours later
100 mL of heat-inactivated 0.5 McFarland NTHi solutions
(n Z 18) in DMEM without FCS were added to the cells.
After 24 h cell-free supernatants were collected and stored
at 80 C until further processing. Cytokine (TNF-a, IL-6
and IL-1b) production in the supernatants was determined
with commercially available ELISA kits (eBioscience,
Vienna, Austria).
Inflammatory responsiveness towards NTHi strains
in a whole blood assay
Next, the potency of the different strains to induce the
release of different inflammatory cytokines was tested in
an ex vivo assay. This whole blood assay (WBA) was per-
formed as described before [23]. Whole blood was
collected in heparin containing vacutainer tubes (BD
Vacutainer, Plymouth, UK) from 24 healthy, young, non-
smoking volunteers (11M/13F, age 21e31 y). The study
was approved by the local ethics committee and informed
consent was obtained from all study participants. For
stimulation with NTHi, starting inocula of 0.5 McFarland in
RPMI (n Z 18) were prepared and heat-inactivated. Ali-
quoted blood of each volunteer was subsequently stimu-
lated with all inactivated bacterial suspensions (100 mL).
After 24 h the cell-free supernatants were collected by
centrifugation and stored at 80 C until further process-
ing. Cytokine production in the supernatants was deter-
mined with commercially available ELISA kits for TNF-a,IL-6 en IL-1b (eBioscience, Vienna, Austria). The limits of
sensitivity were 4 pg/mL for TNF-a, 2 pg/mL for IL-6 and
4 pg/mL IL-1b.
Statistics
To determine significant difference in virulence between
the NTHi isolates, data were analyzed using independent t-
test/One way ANOVA. Data are shown as mean  SEM for
the in vitro models. For all analyses p < 0.05 was regarded
as statistical significant.
Results
Genetic relatedness of NTHi isolates
NTHi isolates were collected from COPD patients partici-
pating in an eight-week inpatient pulmonary rehabilitation
program at CIROþ. During the rehabilitation period, the risk
of cross contamination between patients is present.
Therefore, we initially analysed the NTHi isolates at a
genomic level by PFGE to exclude the possibility that all
isolates examined were members of the same strain. The
genomic fingerprints of clinical NTHi isolates obtained from
different COPD patients and the ATCC strain 49247 are
shown in Fig. 1. PFGE fingerprints were analysed through
the construction of a dendrogram, which shows that the 32
different isolates clustered into 22 different major groups
at the 87% similarity breakpoint, implicating limited cross
contamination between patients and a high genetic di-
versity among NTHi isolates. One dendrogram cluster con-
tains identical profiles or highly related profiles. Based on
this genetic diversity we selected 18 NTHi isolates for
further experiments. All selected strains were classified
into distinct clusters and isolated from 18 different COPD
patients (Table 1) in order to achieve the highest possible
diversity between isolates.
Adherence to lung epithelial cells
As NTHi initiates infections by adhering to the airway
epithelium [24], bacterial adhesion of a selection of the
NTHi isolates to airway epithelial cells was determined
using an in vitro model system. Adhesion was examined
following incubation of A549 cells with the selected NTHi
isolates for 4 h. Although variation in adhesion is observed
between the different strains used (especially strain 2),
results showed that overall there were no major differ-
ences in adhesion between distinct NTHi isolates (Fig. 2).
Inflammatory response in lung epithelial cells
Next, we used the ability of a selection of the NTHi isolates
to induce the expression of the inflammatory defense genes
CXCL-8 and ICAM-1 in airway epithelial cells as an indicator
for the virulence of the strains. Hence, A549 cells were
stimulated with the selected NTHi isolates for 6 h. RT-qPCR
data revealed a low constitutive expression of both ICAM-1
and CXCL-8 mRNA in A549 cells. This expression was
markedly enhanced after stimulation with NTHi isolates.
Figure 1 Dendrogram of NTHi isolates from different COPD patients. Dendrogram was constructed based on the fingerprints
obtained by PFGE using Gel Compare and the unweighted-pair group method of average linkage (UMPGA). It illustrates the patterns
grouping into 22 unrelated clusters based on the breakpoint of 87% similarity. Isolates and their origin are shown in the right
column. 5e10 AE and 5e8 SD isolates were selected from unrelated clusters for further experiments.
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Table 1 Characteristics of COPD patients with sputum
samples containing selected NTHi.
Characteristics NTHi n Z 18
Mean  SD
Gender 10M/8F
Age 66.27  6.70
Gold stage 2.80  1.08
BMI 2.43  0.94
FEV1% 51.36  18.40
Smoking (pack years) 10.70  13.06
148 T.H. Geelen et al.However, the induced expression was not significantly
different between the different NTHi isolates (Fig. 3). In
line with these results is our finding that the NTHi-induced
CXCL-8 release was comparable when A549 cells were
stimulated with the selected isolates (Fig. 3).
Inflammatory response in human macrophages
As macrophages are the sentinel cells for the initiation of
the innate immune response, the capacity of NTHi to elicit
the release of various cytokines by macrophages was
assessed [25]. The ability to produce the pro-inflammatory
cytokines IL-1b, TNF-a and IL-6 of PMA-differentiated THP-
1 was compared as an indicator of virulence. Yet, no sig-
nificant differences were observed in the amounts of in-
flammatory cytokines released by differentiated THP-1
cells following stimulation with either of the NTHi strains
(Fig. 4).Figure 2 Bacterial adherence of NTHi isolates to human
airway epithelial cells (A549). Adherence was determined after
infecting a confluent layer of A549 cells for 4 h with NTHi
isolates. Non-adherent bacteria were removed by vigorous
washing of the cells and the percentage of adherent bacteria
was determined by spiral plating. Values are expressed as the
mean percentage  SEM of four independent experiments of
adherent bacteria relative to the starting inoculum. Although
there’s a tendency that strain 2 may adhere more profoundly,
no statistical significant difference in adhesion between strains
was detected.Inflammatory cytokine production in human
immune cells
Finally, we address the question whether there’s a differ-
ence in the potency of NTHi isolates to induce the pro-
duction of pro-inflammatory cytokines by human blood
immune cell using a whole blood assay (WBA). We want to
emphasize that in this study we deliberately chose to use
blood from healthy young volunteers only. Although it might
be attractive to use blood from COPD patients and/or
matched healthy volunteers, here we were mainly inter-
ested in the immunogenicity of the different NTHi strains
and therefore we tried to exclude as many confounders
because of disease or disease severity.
Whole blood samples from 24 healthy young non-
smoking volunteers were stimulated for 24 h with
different inactivated NTHi suspensions and the cytokines
were subsequently measured in the cell-free supernatants.
Again no significant differences between the NTHi isolates
were observed with respect to the stimulated release of all
cytokines tested. Intriguingly, as shown in Fig. 5, a
remarkable variation in cytokine release was observed. For
example, TNF-a production ranged between 2000 and
30.000 pg/mL. Further analyses revealed that the promi-
nent variability was mainly due to a large inter-individual
variability between volunteers, while the intra-individual
variability was rather limited. For example, Fig. 6 clearly
shows that in some of the volunteers consistently a low
TNF-a release was observed independent of the strain used
(e.g. nr 11, 15, 16, 18 and 19), while others invariably
showed a high TNF-a release (e.g. nr 1, 6, 10 and 14).
Importantly, blood leucocytes counts, which potentially
could explain the large inter-individual differences, were
not correlated with the amount of cytokines produced
(data not shown).Post-hoc analysis including strains origin
We also retracted the isolation origin and analysed the data
accordingly. NTHi isolates were obtained either during the
intake procedure (stable disease, SD) or during acute
exacerbation (AE). Isolates were classified as “SD” when i)
detected in the sputum of the patient solely during the
intake procedure and ii) the patient was clinically stable for
at least 4 weeks. Alternatively, NTHi isolates were classified
as “AE” only when i) isolated from the sputum obtained
during an exacerbation and ii) the sputum sample of the
patient was NTHi culture negative during the intake pro-
cedure. However, these selection criteria do not proof that
the NTHi strain causes the exacerbation.
Next, we examined whether AE- or stable disease (SD)-
associated isolates could be clustered based on their ge-
netic profiles obtained by PFGE. Identical profiles were
shared between AE-isolates obtained from different COPD
patients (e.g. isolates 064508F and 058323X) implicating a
genetic link among AE-isolates (Fig. 1). However, identical
profiles were also observed between AE-isolates and SD-
isolates from different COPD patients (e.g. isolates
069704M and 003908M). Furthermore, SD-isolates could not
be categorized as distinct clusters but were randomly
divided into the major clusters together with the
Figure 3 Relative expression of CXCL-8, ICAM-1 and production of CXCL-8 after NTHi infection by human airway epithelial cells
(A549). Confluent A549 monolayers were infected with different NTHi isolates for 6 h. Values are expressed as the mean relative
expression  SEM of four separate experiments of ICAM-1 (A) or CXCL-8 (B) corrected for b-actin expression. Results revealed no
significant difference between bacterial isolates. CXCL-8 production in the supernatant of A549 cells was determined with ELISA.
Results show the mean CXCL-8 production (C)  SEM in pg/mL of four independent experiments for each bacterial group. No
significant difference in CXCL-8 production was detected between bacterial isolates.
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to discriminate between AE-and SD-isolates. Moreover, as
already shown, strains did not shown significant difference
in the pro-inflammatory capacity in the in vitro assays
indicating that AE-derived strains are not more virulent that
SD-derived strains.
Discussion
Although NTHi infection has been associated frequently
with the development of AE in COPD, not every infection
results in an AE. To explain the different clinical outcomes
after infections, we focused on the virulence of different
NTHi strains, isolated from both stable COPD patients or
patients experiencing an exacerbation. Although we
observed significant genetic variation between the NTHi
isolates analysed by PFGE, the results obtained with the inFigure 4 Pro-inflammatory cytokine response to NTHi. PMA
differentiated THP-1 were stimulated with heat-inactivated
NTHi isolates for 24 h. The proinflammatory cytokines (IL-1b,
IL-6 and TNF-a) production in the supernatant was measured
with ELISA. Results show the mean cytokine production in pg/
mL of each individual NTHi isolates of four independent ex-
periments. No significant difference between different bacte-
rial isolates was detected.vitro models and the WBA did not allow us to determine
whether NTHi isolates were derived from stable or exac-
erbating patients. Interestingly, we found marked inter-,
but not intra-individual differences in immune responses
between different volunteers irrespective of the NTHi
isolate used.
Differential genomic content between NTHi strains has
been linked to variations in bacterial virulence previously
[26,27]. Significant genetic heterogeneity among NTHi iso-
lates was also observed in the present study, which con-
firms earlier data by others [28,29]. Importantly, the
genetic profile of the NTHi strains did not allow us to
classify them as either AE- or SD-derived, as strains from
the same isolation origin did not cluster in separate groups.
Yet, one of the major limitations of the PFGE technique is
that, although it supplies general information on the ge-
netic diversity between different strains, it doesn’t provide
any specific information regarding the presence or absence
of particular genes. This more specific genetic information
may be relevant in terms of virulence since the expression
of particular factors, e.g. specific adhesins on the bacterial
surface [30] or LPS glycoforms variants [31], has been
linked to NTHi pathogenesis. Moreover, strains can differ in
serum resistance, nutritional factors or biofilm capacity and
other virulence factors. Further identification of different
NTHi strains by additional molecular genotyping is there-
fore required before firm conclusions regarding differences
between AE and SD strains at the genetic level can be
drawn.
A functional approach was used to test the capacity of
the different clinical NTHi isolates to induce an inflamma-
tory reaction in different in vitro assays. No significant
differences between different clinical strains were
observed. Interestingly, these results are in contrast with
recent data from Chin and colleagues [12]. In a comparable
approach they observed that AE-NTHi strains showed more
efficient adhesion and induced significantly higher levels of
CXCL-8 in airway epithelial cells in vitro than colonizing
NTHi isolates. Although not entirely clear, there are some
possible explanations for this discrepancy. The most
important is that the current study focussed on difference
in virulence among genetically distinct NTHi strains, while
Figure 5 Whole blood cytokine response to NTHi isolates of
all 24 donors. Shown are the individual cytokine responses of
all donors to all NTHi isolates with its associated overall mean
according to the cytokine type. Whole blood assay (WBA) was
performed using blood from 24 young healthy non-smoking
donors. Results revealed no difference in the amount of cyto-
kines produced between different SD- or AE-NTHi isolates or
the reference strain.
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selection of SD-and AE isolates was more stringent in the
Chin study as they also included the presence or absence of
serum antibodies. This allowed them to more firmly
correlate the appearance of a new specific strain to an AE.
Unfortunately, we were unable to measure the presence of
serum antibody, which is one of the limitations of the
present study. Nevertheless, we only included isolates as AE
strains when patients were culture negative at the time of
intake, which strongly - though not definitively - indicates
that the NTHi strain found during the AE was newly ac-
quired. Furthermore, while Chin et al. used primary humanFigure 6 Variability in cytokine response of the 24 healthy
donors. TNF-a cytokine responses of NTHi isolates stimulated
whole blood assay from healthy volunteers (n Z 24).epithelial cells, in our study we used the A549 cell line.
Although A549 cells are basically human alveolar epithelial
cells, they were originally derived from an alveolar
adenocarcinoma, and it can therefore not be excluded that
they respond differently to external stimuli than primary
cells. On the other hand, primary cells are most likely more
heterogeneous than A549, which leaves open the possibility
that differences found by Chin et al. were primarily caused
by dissimilarities between primary cell cultures rather than
between NTHi isolates.
Next to the lung epithelium, also pulmonary immune
cells like alveolar macrophages are crucial for the host
defence towards invading pathogens. To study the immune
responses elicited by different NTHi strains as indices of
their virulence, it would be preferable to use such primary
lung immune cells. However, this requires rather invasive
methods such as brochoalveolar lavage in healthy persons,
which is for ethical reasons not easy to achieve. Moreover,
on bacterial infection of the airways, circulating blood
monocytes migrate into the sites of infection to govern the
antibacterial immune response with subsequent activation
of local immune effector cells [32]. In view of the latter we
decided to use the monocytic THP-1 cell line to further
examine the virulence of the different NTHi strains. When
treated with PMA, these THP-1 cells differentiate into cells
which closely resemble monocyte-derived macrophages
(MDM). Since MDM represent a good alternative for tissue
macrophages, such as alveolar macrophages, PMA-
differentiated THP-1 cells may represent a useful model
to study the inflammatory response in relation to microbial
stimuli of lung macrophages [33]. However, when these
differentiated THP-1 cells were treated with the distinct
NTHi strains, no significant differences in the release of
pro-inflammatory cytokine were observed, which is in line
with the other in vitro results.
Yet, as the inflammatory reaction is a very complex re-
action, extrapolation of in vitro data regarding the viru-
lence of an infecting NTHi strain to the in vivo situation is
difficult. To translate our in vitro results towards a more
clinical relevant condition we used an ex vivo approach and
we tested the inflammatory properties of the strains with a
WBA [34]. A WBA was chosen because it contains important
innate immune cells and therefore functions as a repre-
sentative model system with limited amounts of cell culture
artefacts. To our knowledge this is the first study which
uses this assay to determine the virulence of different NTHi
isolates. Yet, and in contrast to our expectations, within
each volunteer no pronounced differences were found be-
tween the NTHi isolates regarding the capacity to provoke
the release of cytokines by leucocytes in the WBA. Inter-
estingly, a remarkable inter-individual variation of NTHi-
induced cytokine responses was found among the young,
healthy blood donors, despite a low intra-individual vari-
ability. To explain this pronounced inter-individual vari-
ability, several factors have been suggested, including
genetic polymorphisms. Genes encoding for Toll-Like Re-
ceptors (TLR) are extremely polymorphic and many variants
have been described [35]. For example some TLR4 single
nucleotide polymorphism (SNPs) have been associated with
hyporesponsiveness to LPS [36]. It is tempting to speculate
which possible SNP are responsible for the observed pro-
nounced inter-individual variability, however genes that
Bacterial infections in COPD exacerbations 151regulate this distinction are largely unknown. Despite this,
robust genetic association studies showed convincing evi-
dence between TLR SNP and a spectrum of disease,
including predisposition to infections [37]. On-going in-
vestigations have to prove whether responsiveness of the
(innate) immune system might be an attractive tool to
predict the susceptibility for an individual patient with
respect to the outcome of an infection (e.g. AE vs no AE in
COPD patients).
Conclusion
The results of this study demonstrate that NTHi strains
obtained from different clinical conditions (stable vs
exacerbating COPD patients) do not differ significantly in
terms of virulence as determined with a specific set of
in vitro methods. Moreover, based on the genetic diversity
between strains no clear association with stable disease or
exacerbation was found. On the other hand, we observed a
remarkable inter- but not intra-individual variability with
respect to immune response to the different NTHi strains.
This indicates that the individual immune reactivity might
be an important predictor for the outcome of an infection
of the infecting NTHi strain. And although some earlier
studies in COPD patients already suggest similar large inter-
individual differences between patients [38e41], future
studies are required to examine whether this concept also
applies to COPD patients. As the quality and magnitude of
the innate immune response to bacterial infections might
determine the COPD patients risk to progress to an exac-
erbation, a better understanding of the efficacy of an in-
dividual patient’s immune system may have important
clinical and therapeutic implications. Moreover, stratifica-
tion of COPD patients based on their immunological
responsiveness may eventually contribute to the long-
lasting search for a firm concept to phenotypically char-
acterize COPD patients [42].
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